Grace Therapeutics (GRCE) PT Lowered to $8 at TD Cowen
Tweet Send to a Friend
TD Cowen analyst Stacy Ku lowered the price target on Grace Therapeutics (NASDAQ: GRCE) to $8.00 (from $12.00) ...
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
